Quantum Leap Healthcare Collaborative is a nonprofit research organization that designs and runs platform trials to accelerate better treatments for patients with cancer and other serious diseases.
Your support helps us expand access to life-saving trials, accelerate adaptive research, and bring better treatments to more patients — faster.
Helps support outreach and enablement for under-resourced future trial locations.
Supports site expansion and increased participation across care communities.
Supports adaptive modeling, data systems, and trial learning infrastructure.
Helps stand up new trial sites and future-ready clinical research platforms.
Because of QLHC, breast cancer patients are given intelligent care.
We are proud to hold a Gold Seal of Transparency from Candid, reflecting our commitment to accountability and trust.
Help bring I-SPY and next-generation platform trials to communities that have historically lacked access — so more patients can receive leading-edge therapies closer to home.
Support innovative research platforms to develop safer and more effective therapies that are personalized, so that the right patient, gets the right treatment, at the right time.
Your gift fuels expansion into new diseases and future breakthroughs — including Acute Respiratory Distress Syndrome (ARDS), other cancer types such as colorectal and GI,Ductal Carcinoma in Situ (DCIS), and next-generation trial designs.
Quantum Leap Healthcare Collaborative is a nonprofit research organization that designs and runs platform trials to accelerate better treatments for patients with cancer and other serious diseases.
Through pioneering platforms like I-SPY, we have helped transform how therapies are developed — using smarter clinical trial models that test multiple treatments in parallel, learn in real time, and rapidly identify what works.
By connecting researchers, health systems, regulators, patient advocates, and communities, we help move innovation from discovery to patient impact faster and more efficiently.
Instead of evaluating one treatment at a time, I-SPY tests multiple investigational therapies simultaneously to dramatically increase the speed of discovery.
I-SPY learns and adjusts in real time based on patient response — those patients that respond quickly recieve less therapy. Those patients that respond more slowly have the option to recieve more treatment.
Treatments are aligned to tumor biology and patient characteristics, helping improve outcomes while reducing toxic side effects and improving quality of life.
Help bring clinical trials to more hospitals, health systems, and underserved regions.
Accelerate the evaluation of promising therapies so better options reach patients sooner.
Support expansion into new diseases, next-generation platforms, and patient-first adaptive models.
We want to make giving to Quantum Leap Healthcare Collaborative as easy as possible. There are many ways to contribute, and every one of them makes a difference.
Contact w.raven@qlhc.org for instructions.
Made payable to Quantum Leap Healthcare Collaborative, Attn. Philanthropy, mailed to 580 California St, Suite 1200, San Francisco, CA 94104.
Legal name: Quantum Leap Healthcare Collaborative | EIN: 20-4284925.
Contact e.yuen@qlhc.org for instructions.
Check with your employer's HR department to see if they match charitable gifts. Many will double or triple your contribution, and we handle the paperwork.
Because of QLHC, breast cancer patients are given intelligent care.
